Christine Gebski, See Remarks at REPLIGEN CORP (RGEN), sold 890 shares at $172.25 ($153K) on 2021-05-14, disclosed to the SEC on 2021-05-18.
Open-market sale of $153k RGEN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.25 | 445 | $77K | 50.0% |
| 2 | $172.25 | 445 | $77K | 50.0% |
| Total | $172.25 avg | 890 | $153K | 100% |
| Filing → |
| RGEN | SELL | 2021-09-02 | $1.9M | — | Filing → |
| RGEN | SELL | 2021-03-18 | $276K | — | Filing → |